Ayşe Nur Akınel

Ayşe Nur Akınel

Auto-generated profile, based on publicly available information

Ayşe Nur Akınel


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2022 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
FKFunda Tayfun Kupesiz
Funda Tayfun Kupesiz
AAAyşe Nur Akınel
Ayşe Nur Akınel
HAHilal Akbaş
Hilal Akbaş
ÇSÇiğdem Sivrice
Çiğdem Sivrice
GKGülen Tüysüz Kintrup
Gülen Tüysüz Kintrup
EGElif Güler
Elif Güler
Background: Hepatoblastoma is rare cancer that responds well to risk-based chemotherapy, and surgical treatment is needed to achieve complete remission and satisfactory survival rates in hepatoblastoma patients. In this study, we evaluated the clinical features and treatment outcomes of pediatric hepatoblastoma patients treated in our clinic. Methods: Eighteen patients with hepatoblastoma who were treated and followed up in our center between June 1999 and June 2020 were analyzed retrospectively. All patients were evaluated by a multidisciplinary team and managed using a risk-based protocol (SIOPEL-1 and SIOPEL-3). Results: The patients’ mean age at diagnosis was 38.33 ± 52.34 months. Sixteen patients (89%) received neoadjuvant chemotherapy, and 2 patients (11%) who underwent complete mass excision at diagnosis received adjuvant chemotherapy. After neoadjuvant therapy, the tumor was completely resected in 8 patients (45%), while liver transplantation was performed in 6 patients (34%) because complete resection of the tumor was not possible. Two patients died before surgical treatment. One patient relapsed with lung metastasis after salvage chemotherapy. She is alive without disease at 64 months. The mean follow-up time was 59.3 ± 49.8 months; 5-year overall and disease-free survival rates were 88.9% and 80.8%, respectively. The 5-year overall survival rate was 100% for both liver transplant and resected patients, whereas 5-year disease-free survival was lower in transplant patients (75% vs 100%, P < .001). Conclusion: Multidisciplinary follow-up is especially important for patients who may need liver transplantation. Some patients may benefit from new treatment options such as radiofrequency ablation and cyberknife treatment. Cite this article as: Tayfun Küpesiz F, Akınel AN, Akbaş H, et al. Multidisciplinary management of pediatric hepatoblastoma: A 20-year single-center experience. Turk J Gastroenterol. 2022;33(12):1069-1078.

25 August 2021 in Güncel Pediatri
Verified
Journal Article
Open access
FKFunda Tayfun Kupesiz
Funda Tayfun Kupesiz
GTGülen Tüysüz
Gülen Tüysüz
AAAyşe Nur Akınel
Ayşe Nur Akınel
ATAyşegül Tekneci
Ayşegül Tekneci
ASAyşe Çiğdem Sivrice
Ayşe Çiğdem Sivrice
EGElif Güler
Elif Güler

1 April 2023
Verified
Book
Open access
PDF file
YGYahya Gül
Yahya Gül
ŞKŞeyhan Kutluğ
Şeyhan Kutluğ
EDEsra Dişçi
Esra Dişçi
BYBahtınur Yener
Bahtınur Yener
MCMahmut Cesur
Mahmut Cesur
GKGülizar Koç
Gülizar Koç
Ömrünü eğitime ve tıp bilimine adamış, pediatri alanında kendi eğitimini tamamlayan ve hala sürdüren yazarlarımız ile iki yıldır süren çalışmalarımızın meyvesi olan kitabımız için çok mutluyuz. Yedi yaşından beri gece gündüz demeden çalışan, pediatri uzmanlığını ve yan dalını hakkıyla tamamlamak için çok emek harcayan arkadaşlar, tecrübelerini ve öğrendiklerini eğitime yeni başlayan meslektaşlarına aktarmak için bir kılavuz olacak bu kitabı hazırladık. Bu kitabın; pratisyen hekim, pediatri asistanları ve uzmanlarına klinik pratikte en sık karşılaşacakları hastalıkların tanısı, kliniği ve tedavisi konusunda hızlıca bilgilere ulaşabilmeleri açısından çok büyük kolaylık sağlayacağına inanıyoruz. Bu nedenle acillerde, polikliniklerde ve servislerde sıkça başvurulan bir kitap olacağını düşünüyoruz.